FDA Approves Pfizer's Abrysvo For Pregnant Individuals To Prevent RSV In Infants
22/8 07:26
(RTTNews) - The U.S. Food and Drug Administration announced the approval of Pfizer Inc.'s Abrysvo (Respiratory Syncytial Virus Vaccine) for use in pregnant individuals to prevent respiratory syncytial virus or RSV in infants....